Skip to main content
. 2022 Aug 25;24(12):2283–2296. doi: 10.1111/dom.14829

FIGURE 2.

FIGURE 2

Molecular and pathophysiological interplay between cardiovascular disease, chronic kidney disease and metabolic disease. AGEs, advanced glycated end‐products; ANP, atrial natriuretic peptide; BNP, B‐type natriuretic peptide; ECM, extracellular matrix; ER, endoplasmic reticulum; RAAS, renin‐angiotensin‐aldosterone system; ROS, reactive oxygen species; SNS, sympathetic nervous system; TGF, tubuloglomerular feedback